News Detail
New Delhi, 11 July 2018: India’s drug regulator has ordered the withdrawal of the popular diclofenac painkiller injection marketed by Novartis India Ltd and made by Themis Medicare Ltd, following safety concerns raised by a a health ministry panel.
View DetailsSource : Livemint
Related News
- Court awards Rs. 10 lakhs as damages to Jan Aushadhi in trademark battle (17-10-2024)
- TN Siddha Medical Council Members not Permitted to Store Allopathy Medicine Without License: Madras HC (17-10-2024)
- Amritsar: Pregabalin, Gabapentin intoxicants worth Rs 14.80L seized in Katra Sher Singh (17-10-2024)
- Cipla, Alkem eye Rs 4,000 crore stake in India's largest stent manufacturer (17-10-2024)
- Health worker arrested for mixing TB patient’s sputum in doctor’s food (17-10-2024)
- DoP directs NPPA to recalculate ceiling prices of three antibiotics based on Cipla's applications (17-10-2024)
- CSIR-NIIST to establish centres of excellence in Ayurveda, performance chemicals (17-10-2024)
- India, Uzbekistan discuss ways to ensure quality, safety in pharma sector (17-10-2024)
- Woman accused arrested with 127 pieces of cough syrup (16-10-2024)
- Raid on unlicensed medical store in Sakchi: Large stock of banned medicines found (16-10-2024)